Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

PharmaMar Licenses Rights to Cancer Candidate for Southeast Asia, Australia

Specialized Therapeutics Asia (STA) will market PharmaMar’s cancer candidate lurbinectedin (PM1183) in Australia, New Zealand, and 12 Southeast Asian ...

Forward this item to a colleague:


(Separate multiple addresses by commas)